TLR4 and myeloid sarcoma: Data of TLR‐4 as one of the biomarkers of MS that plays a major role in the pathogenesis of this disease showed an increase in TLR‐4 gene expression in EAE rats (Figure 6b, EAE: 4.2 fold, p < .001; EAE + AgB: 2.86 fold, p < .01; EAE + TF: 2.22 fold, p < .01) compared with the saline group.